Lymecycline

Lymecycline is a tetracycline broad-spectrum antibiotic. It is approximately 5,000 times more soluble than tetracycline base and is unique amongst tetracyclines in that it is absorbed by an active transport process across the intestinal wall. Bacteriostatic antibiotic with actions, adverse effects, and interactions almost similar to tetracycline.

Lymecycline is primarily indicated in conditions like Acne vulgaris, Amoebiasis, Bacterial infections, Brucellosis, Endocarditis, Ornithosis, Pneumonia, Psittacosis, Rickettsia, Syphilis, and can also be given in adjunctive therapy as an alternative drug of choice in Acute sinusitis, Chronic bronchitis, Helicobacter pylori infection, Soft tissue infections, Trachoma.

Lymecycline is contraindicated in conditions like Systemic lupus erythematosus.

The severe or irreversible adverse effects of Lymecycline, which give rise to further complications include Increased blood urea nitrogen, Hyperphosphatemia, Acidosis, Azotemia. Lymecycline produces potentially life-threatening effects which include Anaphylaxis, Acute hepatic dysfunction. which are responsible for the discontinuation of Lymecycline therapy. The symptomatic adverse reactions produced by Lymecycline are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Diarrhea, Stomatitis, Vaginitis, Photosensitivity, Glossitis, Increased intracranial pressure, Enamel hypoplasia, Stomach pain.

Tetracyclines should only be used with caution in patients with hepatic dysfunction, lest accumulation occurs with increased toxicity. Careful monitoring of dosage by serum levels is necessary. High dosage of tetracyclines may be hepatotoxic and great care should be used with concurrent administration of other hepatotoxic drugs. Tetracyclines should only be administered with great caution in patients with renal insufficiency lest accumulation occurs with increased toxicity. Dosage may require reduction. High dosage of tetracyclines may be nephrotoxic.

Drug should not be given to Pediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, and Neonates. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

1.428 to 2.857 mg/kg (2.1 (2.1425)) 8 hourly PO — - 2.857 to 4.285 mg/kg (3.6 (3.571)) As recommended. IV — As Required

No child dosage information is recorded for this medicine yet.

No neonatal dosage information is recorded for this medicine yet.

No data regarding the interactions of Lymecycline was found.

Caps Store Below 25°C. Protect from Sunlight.